RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 171 filers reported holding RELAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $127,000 | +7.6% | 15,158 | +60.9% | 0.00% | – |
| Q2 2023 | $118,000 | +49.4% | 9,420 | +95.5% | 0.00% | – |
| Q1 2023 | $79,000 | -63.4% | 4,818 | -66.7% | 0.00% | – |
| Q4 2022 | $216,000 | +644.8% | 14,450 | +1022.8% | 0.00% | – |
| Q3 2022 | $29,000 | +314.3% | 1,287 | +198.6% | 0.00% | – |
| Q2 2022 | $7,000 | -94.6% | 431 | -90.0% | 0.00% | – |
| Q1 2022 | $129,000 | -86.3% | 4,299 | -86.0% | 0.00% | – |
| Q4 2021 | $944,000 | +56.0% | 30,728 | +60.5% | 0.00% | – |
| Q3 2021 | $605,000 | +298.0% | 19,150 | +361.1% | 0.00% | – |
| Q2 2021 | $152,000 | +16.9% | 4,153 | +10.3% | 0.00% | – |
| Q1 2021 | $130,000 | +828.6% | 3,765 | +997.7% | 0.00% | – |
| Q4 2020 | $14,000 | +1300.0% | 343 | +1082.8% | 0.00% | – |
| Q3 2020 | $1,000 | – | 29 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 6,923,574 | $58,227,257 | 6.44% |
| Finepoint Capital LP | 870,870 | $7,324,017 | 3.65% |
| Nextech Invest Ltd. | 1,196,409 | $10,061,800 | 3.05% |
| MPM BioImpact LLC | 1,352,133 | $11,371,439 | 3.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $234,680,739 | 1.93% |
| EcoR1 Capital, LLC | 4,163,824 | $35,017,760 | 1.18% |
| Integral Health Asset Management, LLC | 800,000 | $6,728,000 | 0.93% |
| Alphabet Inc. | 1,568,753 | $13,193,212 | 0.85% |
| HARBOURVEST PARTNERS LLC | 296,402 | $2,492,741 | 0.85% |
| Boxer Capital, LLC | 1,819,132 | $15,298,900 | 0.81% |